On December 30, 2025 GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, reported that Per Langoe, Chief Executive Officer of GT Medical Technologies, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2026, at 4:00 PM PT in San Francisco, CA.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"We are honored to be presenting at the J.P.Morgan Healthcare Conference, reflecting the impact GammaTile has made in 2025 and the strong momentum we carry into 2026," said Per Langoe. "GammaTile continues to show strong clinical outcomes and evidence that are challenging the status quo for operable brain tumors. In addition, I am excited to share how the execution of our commercial strategies and programs, combined with strong revenue growth and enhanced operations support will allow for an increasingly scalable business model."
(Press release, GT Medical Technologies, DEC 30, 2025, View Source [SID1234661661])